WASHINGTON (Kyodo) The U.S. Food and Drug Administration warned Wednesday that health risks are higher for Asian people than other racial groups using the cholesterol-lowering drug Crestor.

Crestor was developed by Japan's Shionogi & Co. and is marketed by Britain's Astra-Zeneca Pharmaceutical LP.

The finding is likely to call into question the health risks on Japanese as Shionogi has said it used overseas clinical test data in applying for Crestor's approval in Japan. Its production and sales in Japan were approved in January.